Showing results (181-190 of 741) with videos related to

Sort By:
Pageof 75
Blood|November 9, 2011
Immunoglobulin D amyloidosis: a distinct entityMorie A Gertz, Francis K Buadi, Suzanne R Hayman, et al.
Blood Cancer Journal|November 10, 2018
Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myelomaM Hasib Sidiqi, Mohammed A Aljama, Irbaz Bin Riaz, et al.
Blood|June 25, 2014
Trends in survival of patients with primary plasma cell leukemia: a population-based analysisWilson I Gonsalves, S Vincent Rajkumar, Ronald S Go, et al.
American Journal of Hematology|May 3, 2012
Trends and outcomes of modern staging of solitary plasmacytoma of boneRahma Warsame, Morie A Gertz, Martha Q Lacy, et al.
Haematologica|August 2, 2016
Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen typeEli Muchtar, Angela Dispenzieri, Shaji K Kumar, et al.
Blood Cancer Journal|November 17, 2018
Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myelomaPraful Ravi, Shaji K Kumar, Lindsey Roeker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Promising preclinical activity of 2-methoxyestradiol in multiple myelomaDavid Dingli, Michael Timm, Stephen J Russell, et al.
Hematology/Oncology Clinics of North America|September 13, 2014
Monoclonal gammopathy of undetermined significance and smoldering multiple myelomaRobert A Kyle, Jesus F San-Miguel, Maria-Victoria Mateos, et al.
Blood|June 9, 2025
Eliminating the need for sequential confirmation of response in multiple myelomaJean-Sébastien Claveau, Prashant Kapoor, Moritz Binder, et al.
European Journal of Haematology|February 8, 2014
Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplantRahma Warsame, Soo Mee Bang, Shaji K Kumar, et al.
Pageof 75